Increasing Prevalence of Asthma and Emergence of Covid-19 to Augment Growth of Respiratory Drug Delivery Formulation Market

  


Respiratory drugs can be delivered to the body in different ways. The most common form is through inhalation. Oral or intravenous delivery are other common methods. Respiratory drugs are used for the treatment of different respiratory disorders. They include medicines for treatment of influenza, pneumonia, chronic obstructive pulmonary diseases, and some common forms of allergy such as food allergies and rhinitis.

Market Dynamics

Increasing prevalence of asthma is expected to propel growth of the global respiratory drug delivery formulation market. For instance, According to The Global Asthma Report 2018, around 300 million people have asthma worldwide, and the number is expected to reach 100 million by 2025.

Moreover, initiatives to boost adoption of dry powder inhalers is also expected to aid in growth of the market. For instance, in September 2018, researchers from University of Helsinki, Finland, reported investigation of non-verbal, demonstrational videos as a method of teaching inhaler naïve individuals how to use a dry powder inhaler.

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global respiratory drug delivery formulation market. For instance, globally, as of 4:32pm CET, 30 December 2020, there have been 80,773,033 confirmed cases of COVID-19, including 1,783,619 deaths, reported to the World Health Organization. Moreover, launch of solutions to track usage pattern of metered-dose inhalers is also expected to aid in growth of the market. For instance, in November 2019, Lupin Ltd. launched a device – Adhero – to track usage pattern of metered-dose inhalers (MDI) by patients suffering from chronic respiratory diseases.

Major players operating in the global respiratory drug delivery formulation market are focused on approval and launch of new products to expand their product portfolio. For instance, in September 2019, Novartis International AG’s Concept1 inhaler received certification under the new EU Medical Devices Regulation (MDR).

Competitive Analysis

Major players operating in the global respiratory drug delivery formulation market include, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, 3M, AstraZeneca plc, Merck and Co., Inc., Omron Corporation, Novartis AG, Glenmark Pharmaceuticals, Boehringer Ingelheim GmbH, Sunovion Pharmaceuticals Inc., Hovione, Cipla Ltd., Catalent Pharma Solutions, and Aphios Corporation.

Major players operating in the global respiratory drug delivery formulation market are focused on approval and launch of new products to expand their product portfolio. For instance, in April 2019, Glenmark Pharmaceuticals launched two new steroid inhalers that include Soprobec (beclometasone), a metered-dose aerosol inhaler, and Stalpex (salmeterol/fluticasone), a breath-actuated inhaler. Similarly, in April 2019, Cipla Ltd. launched Niveoli, an extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults, which can be used for the treatment of asthma and COPD.

Comments

Post a Comment

Popular posts from this blog

Intec Pharma Ltd. Partnered With LTS Lohmann Therapie-Systeme AG ("LTS") For Levodopa Market

Image
  Advancement in the diagnosis of Parkinson's disease (PD) progression is propelling the growth of the levodopa market. For instance, researchers continue developing new treatments for Parkinson's disease, treatments that give real hope for people suffering from the disease. Some treatments currently being studied involve fetal cell transplantation, the use of stem cells, and gene therapy. Moreover, the development of novel formulations and drug delivery methods for levodopa is also contributing to the growth of the levodopa market . Levodopa is known by many names, including chelation therapy, L-carnitine, and nutritive adjuvant. It is a naturally occurring substance found in most tissues of the body, including the brain, heart, liver, kidney, pancreas, lungs, stomach, small intestine, and skeletal muscle tissue. This substance is often taken to treat various diseases, including Parkinson's disease and depression. As dopamine is responsible for feelings such as pleasure ...
Read more

The Growing demand for the Electronic Nose Market Act As a Defense against Hazardous Environment

Image
  An electronic nose is an electronic device designed to detect certain flavors or odors in the air. When used, it allows for a more thorough sniffing of the air. A good example of an electronic nose used in foodservice would be a system designed to test for chemicals in the air. While there are several of these devices available on the market. They do provide a better way of evaluating the air than using a standard air sampling kit. This would also allow the odor or flavor to be determined. For instance, if a product was selling very well in an area, but it was producing a noticeable smell in areas where it was not being sold, it could be a sign that the odor or flavor was in fact present. This type of odor detection is not possible by an air sampling device alone. Another category of electronic noses is the one designed for detecting the aroma of certain foods The growing demand for the electronic nose market as a defense against hazardous environments for consumer goods and t...
Read more

Increasing Prevalence of Obesity across Developing Countries Is Accelerating the Growth of the Weight Loss Diet Products Market

Image
  Weight loss diet products have been available in the market for many years. They come in various forms such as appetite suppressants, meal substitutes, and quick weight loss supplements. The growing obese population around the globe is driving the growth of the weight loss diet products market . According to the World Health Organization, in 2019, an estimated 38.2 million children under the age of 5 years were overweight or obese.   Overweight and obesity are now on the rise in low- and middle-income countries, particularly in urban settings. Almost half of the children under 5 who were overweight or obese in 2019 lived in Asia. Moreover, the growing prevalence of various chronic diseases such as diabetes and cardiovascular diseases is again fostering the growth of the market. Changing eating habits coupled with the sedentary lifestyle is again increasing the cases of obesity which is further augmenting the growth of the weight loss diet products market. From the geogra...
Read more